৳ 0.00
Your Complete HealthCare Solution - Right Here
10657
info@shukhee.com
Telecom Bhaban (Level- 12), 53/1 Box Nagar, Zoo Road, Dhaka-1216.
৳ 0.00
10657
info@shukhee.com
Telecom Bhaban (Level- 12), 53/1 Box Nagar, Zoo Road, Dhaka-1216.


Products
Payment
Delivery
Rovator tablet is indicated for:
. Patients with primary hyperlipidemia and mixed dyslipidemia as an adjunct to diet to reduce elevated total-C, LDL-C, ApoB, non HDL-C and TG levels and to increase HDL-C.
. Patients with hypertriglyceredemia as an adjunct to diet.
· Patients with primary dysbetalipoproteinemia (Type III hyperlipoproteinemia) as an adjunct to diet.
. Patients with homozygous familial hypercholesterolemia (HoFH) to reduce LDL-C, total-C, and ApoB.
. Slowing the progression of atherosclerosis as part of a treatment strategy to lower total-C and LDL-C as an adjunct to diet.
. Pediatric patients 10 to 17 years of age with heterozygous familial hypercholesterolemia (HeFH) to reduce elevated total-C, LDL-C and ApoB after failing an adequate trial of diet
therapy.
. Risk reduction of Myocardial Infarction (MI), stroke and arterial revascularization procedures in patients without clinically evident CHD, but with multiple risk factors.
Drug Class
Combination of a statin (Rosuvastatin) and a cholesterol absorption inhibitor (Ezetimibe).
Belongs to the class of lipid-lowering agents.
Purpose
Used to treat hyperlipidemia (high cholesterol).
Helps reduce LDL cholesterol (“bad cholesterol”) more effectively than either drug alone.
Prescribed to lower the risk of heart attack, stroke, and other cardiovascular diseases.
Mechanism
Rosuvastatin: Blocks HMG-CoA reductase in the liver, reducing cholesterol production.
Ezetimibe: Prevents absorption of cholesterol from the intestine.
Together, they provide dual action—less cholesterol made in the liver and less absorbed from food.
Advantages
Stronger LDL reduction: More effective than statin alone.
Convenient combination: Two medicines in one tablet reduce pill burden.
Cardiovascular protection: Helps prevent complications in patients with high cholesterol or existing heart disease.
Well tolerated: Generally safe with proper monitoring.
Dose:
Commonly available as Rosuvastatin (5–20 mg) + Ezetimibe (10 mg) tablets.
Usual dose: Once daily, taken with or without food.
Exact dosage must be prescribed by a doctor depending on cholesterol levels and patient condition.




Stronger LDL reduction: Lowers “bad cholesterol” (LDL) more effectively than statin alone.
Dual mechanism: Rosuvastatin reduces cholesterol production in the liver, while Ezetimibe blocks absorption from food.
Cardiovascular protection: Helps reduce risk of heart attack, stroke, and other complications.
Convenient combination: Two medicines in one tablet, reducing pill burden.
Improves treatment response: Useful for patients who do not reach target cholesterol levels with statin alone.
Well tolerated: Generally safe with proper monitoring of liver function and muscle health.





